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Background: High diagnostic accuracy is reported for magnetic resonance enterography (MRE) in Crohn’s disease (CD), but few studies have
evaluated its role in abdominal ﬁstulae. The primary aim of this study was to assess the reliability of MRE in the identiﬁcation of internal ﬁstulae in CD.
Methods: One hundred and eighty-six patients with moderate CD (CD Activity Index : 250–400) were prospectively selected from the inﬂammatory bowel
disease clinic of Parma University Hospital. Eligible patients had already undergone nutritional screening, pancolonoscopy, and computed tomography enter-
ography (CTE) in themonthbefore enrollment.MREwasperformedaccording to the studyprotocol.Additionalﬂuoroscopic contrast-enhanced studies or surgical
evaluation were used for discordance between CTE andMRE results. A consensus committee resolved equivocal ﬁndings. Surgical ﬁndings and/or ﬂuoroscopic
contrast-enhanced studies together with the clinical data were considered the composite “reference standard” to which the results of MRE were compared.
Results: MRE identiﬁed 22 internal ﬁstulae in 21 patients (11%), of whom 4 (19%) also had perianal ﬁstulae and found 7 abscesses (33%). Forty-one
(22%) additional patients with perianal ﬁstulae were identiﬁed. Thirteen patients (57%) with internal ﬁstulae required enteral nutrition support. No
statistically signiﬁcant differences were found between MRE and CTE in ﬁstula detection. There was also no signiﬁcant difference between MRE and the
composite diagnosis in those who underwent surgery (n ¼ 8) and/or contrast-enhanced studies (n ¼ 7).
Conclusions: CTE and MRE accurately detect internal ﬁstulae in CD. MRE is preferable because it avoids radiation. Reliable identiﬁcation of internal
ﬁstulae by MRE should permit earlier and improved treatment.
(Inﬂamm Bowel Dis 2013;19:1896–1903)
G astrointestinal (GI) ﬁstulae are abnormal duct-like commu-nications between the gut and another epithelial-lined sur-
face, such as another organ, the skin surface, or elsewhere along
the GI tract itself. The development of a GI ﬁstula can markedly
increase morbidity and mortality, rendering detection of the ﬁstula
critical. Fistulae are frequent problems in patients with Crohn’s
disease (CD). The reported incidence ranges from 17% up to
50%,1–4 and population-based studies support the higher ﬁgures.5
Internal ﬁstulae have been classiﬁed clinically into 2 types: those
which form an internal connection between 2 bowel segments and
those that occur between the intestine and other organs, such as
the bladder (enterovesical) or abdominal wall (enterocutaneous).6
The identiﬁcation of complications of CD, and in particular
ﬁstulae, is vital to facilitate optimal clinical management. Internal
ﬁstulae are, for example, relatively common causes of malabsorption
and intestinal failure in patients with CD, even though these
enteroenteric ﬁstulae are often difﬁcult to diagnose.7 Indeed, it is
possible that much subclinical malnutrition and dietetic deﬁciency
in CD is related to undiagnosed internal ﬁstulae. It is logical and
potentially very important to identify such patients and accurately
stage their disease, so that the correct medical or surgical treatment
can be initiated. Furthermore, the accurate detection of internal ﬁstulae
allows better classiﬁcation of patients (those with penetrating versus
nonpenetrating CD according to the Vienna and Montreal Classiﬁca-
tions) and therefore better prognostic assessment and more accurate
selection for clinical trials.8 Another important consideration is that
an increased risk of cancer is reported in patients with CD who
have bowel segments bypassed by internal ﬁstulae.9 A recent meta-
analysis10 demonstrated an increased risk of small bowel, colonic, and
extraintestinal carcinoma and of lymphoma in patients with CD,
which may be accounted for in part by this phenomenon.
Imaging plays a pivotal role in the diagnosis and manage-
ment of GI ﬁstulae. Fluoroscopic contrast-enhanced studies have
served as the traditional ﬁrst-line investigation, but the emergence
of cross-sectional imaging techniques has already substantially
modiﬁed the radiological approach to diagnosis and classiﬁcation.
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There is, however, ongoing debate about the optimal imaging
for complications and ﬁstulae. Currently, barium enteroclysis and
abdominal computed tomography (CT) scan represent the standard
diagnostic procedures in most institutions, despite the fact that they
may miss .30% of internal ﬁstulae detected at surgical interven-
tion.11–13 Furthermore, they both deliver non-negligible amounts
of ionizing radiation to a generally young population potentially
requiring lifelong repeated imaging. The effective dose of a single
abdominal–pelvic CT scan is, for example, over 10 mSv, and the
hazards of ionizing radiation are thought to be cumulative with
repeated examinations.14 Modeling suggests that in the United States,
.1% of all malignancies are now invoked by diagnostic medical irra-
diation, and the patient with CD would seem to be at particular risk.
Despite several studies reporting promising results in the
detection and classiﬁcation of internal ﬁstulae, very few have
prospectively evaluated the accuracy of magnetic resonance
enterography (MRE) in detecting small bowel ﬁstulae in CD.
Our primary end point was therefore to assess the reliability of
MRE in the precise identiﬁcation of ﬁstulae in CD. A key
secondary end point was to evaluate the impact of internal ﬁstulae
on the nutritional and clinical status of patients with CD. We also
aimed to seek and evaluate potential neoplastic changes in
intestinal segments bypassed by internal ﬁstulae.
MATERIALS AND METHODS
Patients
Patients with moderate CD (CD Activity Index [CDAI]:
250–400)15,16 were prospectively selected from those attending the
inﬂammatory bowel disease (IBD) clinic of Parma University Hos-
pital between May 2008 and May 2010. Patients with moderate CD,
only, were included to obtain adequate statistical power based on the
prevalence data forﬁstulisingCD (30%, see power calculation below).
Inclusion criteria were a staging colonoscopy, CT enter-
ography (CTE), and/or ﬂuoroscopic small bowel imaging within
the past month, and diary data to permit the calculation of the
CDAI. In each case, CD had been deﬁned using the standard
criteria of a characteristic history and at least 2 among typical
endoscopic ﬁndings, characteristic radiology, supportive histol-
ogy, or typical surgical ﬁndings.15,16
Patients were excluded from the study if they had fulminant
CD requiring parenteral steroids and hospitalization or were in need
of imminent surgery. Patients with serious infections in the
preceding 3 months, opportunistic infections within 1 month, or
current signs or symptoms of severe, progressive or uncontrolled
renal, hepatic, hematological, endocrine, pulmonary, cardiac, neu-
rological, or cerebral disease were excluded. Patients were excluded
if they had a history of seizure, epilepsy, current central nervous
system tumor, or of anorexia nervosa or bulimia. Patients were
excluded if they were abusing alcohol or had alcohol dependence.
Patients in whom a delay of .1 month had occurred between
diagnostic evaluation and/or surgery, and patients presenting with
severe biochemical abnormalities suggestive of major metabolic
complications, were excluded. Those younger than 18 years and
pregnant and lactating females were also excluded.
The aim was to recruit 186 patients with moderate CD, this
sample size having been calculated from published prevalence
data on ﬁstulae in CD, hypothesizing that MRE has a high
diagnostic accuracy for penetrating disease (sensitivity 0.76 and
speciﬁcity 0.96). The statistical signiﬁcance of the differences in
sensitivities between MRE and reference standards were assessed
by means of a test for difference in proportions (P , 0.05 was
considered signiﬁcant). A statistical power of 90% with an alpha
of 10% was ﬁxed to detect ﬁstulae at a prevalence of 30%.17–19
The study protocol was devised in line with the Helsinki
Declaration of 1964, as revised in 1989, and underwent review
and approval by the Parma Local Research Ethics Committee.
Written informed consent was obtained from all participants.
Initial Non-study Investigations
Before recruitment, and necessarily so for eligibility, all
patients to be enrolled had already undergone pan-colonoscopy and
CT enteroclysis (CTE), as part of their routine clinical investigation
in the IBD unit of Parma University Hospital. Only a small
proportion (32%; n ¼ 59) had undergone double contrast small
bowel radiography (12%; n ¼ 21) or barium follow through (20%;
n ¼ 38). These investigations formed part of the patients’ standard
clinical care in the assessment of presumed mild-to-moderate CD and
were in that respect independent of their subsequent participation in
the study. Colonoscopy was performed according to the suggested
standards for colorectal cancer screening in accordance with the
American Society for GI Endoscopy Guidelines.20
The CT enterography protocol included administration of
a total of 1.35 L O.1% wt/vol barium sulfate suspension (VoLu-
men, Bracco Diagnostics; Princeton, NJ) as a negative oral
contrast agent. A bolus of intravenous contrast material (125
mL, Isovue 370; Bracco Diagnostics) followed by 50 mL of saline
solution was then administered with a power injector at a rate of 4
mL/seconds. Helical scanning was performed from the diaphragm
to the symphysis pubis, beginning 65 seconds after the adminis-
tration of intravenous contrast material including a single
(venous) phase. Scanning parameters included a section thickness
of 0.625 mm and interval of 0.625 mm. Postprocessing techniques
included axial image reconstruction with a section thickness of
2.5 mm and an interval of 2.5 mm, reformatting of axial image
data for coronal and bilateral oblique (30-degree angulation)
maximum intensity projections, and volume rendering. Multi-
planar reformatting of axial image data allowed excellent
demonstration and characterization of enteric and extraenteric
abnormalities.
Interventions
All previous abdominal CT scans and small bowel enter-
oclysis/barium examinations were reviewed by the gastroenterol-
ogists of the Parma IBD team in conjunction with the consultant
GI radiologist. Only patients who had undergone their most recent
procedures in the 4 weeks preceding the enrollment date were
considered eligible for the study. The IBD team reviewed the
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technical quality of all clinical scans and if diagnostic quality was
deemed unacceptable, they were repeated.
Nutrition screening was performed with the malnutrition
universal screening tool and subjective global assessment. This
approach identiﬁes undernourished patients and those who are at
increased risk of malnutrition. Those with conﬁrmed malnutrition
are at higher risk of medical complications and are thought to
beneﬁt from speciﬁc nutritional therapy.21
Patients underwent MRE according to the study protocol. An
antiperistaltic agent (hyoscine butylbromide 20 mg intravenously)
was injected to minimize potential artifacts caused by bowel
movement or contraction. Imaging (Achieva, 1.5T; Philips, Ann
Arbor, MI) was performed with the patient in the prone position.
A biphasic contrast agent (polyethylene glycol) was administered
orally in the magnetic resonance (MR) suite. Once bowel distension
was deemed adequate, through rapid and sequential axial sequences
True-FISP (fast imaging with steady-state precession), MRE was
performed as follows: axial and coronal T2-weighted imaging
employing HASTE and SSFP sequences with and without fat
saturation, in combination with parallel imaging, and dynamic 3D
T1-weighted imaging using a post-gadolinium (gadolinium dose
0.1 mmol/kg and 3 mL/sec infusion rate; MultiHance; Bracco
Diagnostics) image acquisition at 30, 60, and 90 seconds in the
axial plane. MRE reporting was carried out by 2 experienced
consultant radiologists working in consensus. At this stage,
radiologists were blinded to initial nonstudy investigation results.
Conﬁrmatory tests were performed in patients in whom
MRE suggested a ﬁstula but prestudy CTE, colonoscopy, and
barium follow through (BaFT) were negative. In the case of MRE-
diagnosed enteroenteric ﬁstula, the BaFT or CTE (depending on the
negative procedure) was repeated if the consensus panel (see below
for full description of the consensus panel) thought MRE was con-
vincing. If the MRE, CTE, colonoscopy, and BaFT were negative,
but the gastroenterologists still suspected a ﬁstula, for example, due
to the persistence of external discharge or watery diarrhea and
malabsorption, then consensus panel review with 6 months clinical
follow-up was carried out and a further and ﬁnal consensus opinion
as to whether the MRE was a true or false negative had to be
expressed. The quality of all examinations were deemed sufﬁcient by
the performing/reporting radiologists, such that none needed to be
repeated. However, a formal quality grading score was not applied.
In clinically hypothesized ﬁstula (deﬁned as 1 visualized
on a single imaging modality—MRE, prestudy CTE, BaFT—or
high clinical suspicion despite negative imaging), patients were
selected for ﬂuoroscopic contrast-enhanced studies and/or surgery
as follows.
Enterovesical Fistulae
Cystography was performed with a standard technique as
follows: a Foley urinary catheter was placed and the bladder
emptied. A 300-mL bottle of diatrizoate meglumine with 30%
ionic contrast (150 mg/mL) (Reno-Dip; Bracco Diagnostics) was
connected to the Foley catheter and instilled into the bladder. At
bladder ﬁlling, oblique radiographs were obtained if the patient
could be safely turned, followed by an anterior posterior
radiograph after draining the contrast from the bladder.
Rectovaginal Fistulae
Clinical and unsedated speculum examination was carried
out in an attempt to document a suspected ﬁstula and to deﬁne its
tract. The integrity of the anal sphincter was assessed by digital
examination, with manometry, and/or endoanal ultrasound. The
surrounding tissues were assessed by digital examination, ano-
scopy, and proctoscopy. When examination in the ofﬁce setting
proved inadequate, an examination under anesthesia was ar-
ranged. Patients were allocated to one of 3 possible outcome
groups and future planning was deﬁned. If a simple rectovaginal
ﬁstulae was identiﬁed, the evaluation was considered complete
and planning for surgical repair of the ﬁstula began. If a complex
rectovaginal ﬁstulae was identiﬁed, further evaluation was
sometimes necessary depending on the site and etiology. In some
cases, after completion of examination under anesthesia, it was
not possible to identify the potential ﬁstula tract. In this case,
a vaginogram with water-soluble contrast followed by a barium
enema was considered in an attempt to disclose the ﬁstula tract.
Enterocutaneous Fistula
Anatomical deﬁnition of the tracts in enterocutaneous
ﬁstula, with their secondary and internal openings, is difﬁcult.
At present, conventional radiographic ﬁstulography has the most
professional support, in our experience22, and this was the inves-
tigation adopted as “standard” in the study. However, it cannot be
easily or frequently repeated and has been reported to be associ-
ated with dissemination of septic ﬁstulous content.23 Moreover, it
provides very little information on the affected bowel segments,
thus making it necessary to perform additional diagnostic exami-
nations, such as small bowel enteroclysis and/or barium enema to
plan treatment.
Enteroenteral (Internal GI) Fistula
For internal intestinal (gut-to-gut) ﬁstulae, enteric contrast-
enhanced studies were considered “standard” for this study. A
water-soluble iodinated contrast agent was used when frank perfo-
ration was suspected or pneumoperitoneum was present.24,25 When
no free communication was thought, likely barium imaging was
used.26,27 Negative water-soluble contrast studies were followed
by a barium study when the index of suspicion remained high.
The consensus panel included consultant gastroenterolo-
gists, radiologists, and surgeons not otherwise involved in the
study, to evaluate contradictory results independently and to judge
the diagnostic performance of MRE in CD ﬁstulae. The panel
members were 2 gastroenterologists, 2 colorectal surgeons with an
interest in IBD, and 2 consultant radiologists with longstanding
experience in GI imaging. When MRE suggested a ﬁstula not
recorded by conventional imaging tests or colonoscopy, the panel
reviewed the full clinical notes (including ﬁndings at surgery and
all imaging/endoscopic investigations) with at least 6-month
follow-up. A consensus decision was then made on the absence
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or presence and location of any internal ﬁstulae. During the
consensus deliberations, appropriate weight was placed on the
known diagnostic performance of each investigation, other than
the MRE, to reduce the risk of introducing bias. Radiologists
interpreting CTE, MRE, and contrast-enhanced studies were
experienced consultants with at least 10 years of relevant practice.
Surgical ﬁndings and/or ﬂuoroscopic contrast-enhanced studies
together with the clinical data were therefore considered the composite
“reference standard” to which the results of MRE were compared.
The reference standards were considered on a per-patient basis to
analyze data against the different references at the end of the study.
A result was considered to be a true positive when at least
1 ﬁstula identiﬁed at MRE, barium radiology, or CT scan matched a
lesion observed intraoperatively or by ﬂuoroscopic contrast-enhanced
studies. The presence of cancer or suspected neoplasm in the
bypassed bowel loops of the internal ﬁstula was also to be reported.
The original data were recorded onto anonymized CD-ROMs
to aid data protection and assigned to the consensus panel for
storage. The consensus panel also supervised data collection and
statistical analysis. Results of the diagnostic procedures were
analyzed on a per-patient basis, in accordance with other studies17,28
with the intent of identifying the CD behavior type (ﬁstulising
versus no ﬁstulising).
A Fisher’s exact test was used for comparing sensitivity and
speciﬁcity of different procedures (P , 0.05 was considered sig-
niﬁcant). Statistical analysis was performed with commercially
available software (Stata 11 for Windows, College Station, TX).
RESULTS
There were 25 patients (of 194 considered eligible for the
study) with a diagnosis of moderate CD and a ﬁnding of internal
ﬁstula in the radiology reports, as conﬁrmed by the consensus panel.
Of these, 2 were excluded because the ﬁnal diagnosis was revised
from CD to diverticulitis. Internal ﬁstulae were therefore present in
11.2% of the patients with CD. One patient had 2 internal ﬁstulae.
The ﬁstulae were distributed as follows: 15 between different
segments of the intestinal tract, 4 enterovaginal, 2 enterovesical,
and 2 enterocutaneous. Of these 23 patients, 6 (28%) also had
perianal ﬁstula and 7 (33%) had a current abdominal abscess.
Forty-one patients (22%) with CD and perianal ﬁstulae
were identiﬁed by T2-weighted magnetic resonance imaging with
fat suppression (Table 1). In 1 patient with perianal ﬁstula, the
identiﬁcation of a clinically suspected enterovesical ﬁstula
required a contrast-enhanced study, and this patient therefore
had perianal and enterovesical ﬁstula (Fig. 1). There was no sig-
niﬁcant (P ¼ 0.49) difference in the diagnostic yield for internal
ﬁstulae between MRE and the composite gold standard. In fact,
MRE detected 22 of 23 ﬁstulae (sensitivity ¼ 0.91). Only 1 ﬁstula
needed ﬂuoroscopically enhanced study for detection, prompted
by previous review of the previous 6-month clinical notes.
No statistically or clinically signiﬁcant differences were
found in diagnostic efﬁcacy between MR examinations and CT
scan for the detection of internal ﬁstulae. Conventional contrast-
enhanced studies detected only 16 internal ﬁstulae (sensitivity ¼
0.73), this constituting a numerical deﬁciency in comparison with
CT scan and MR (P ¼ 0.11). Most of the ﬁstulating patients with
CD had a normal C reactive protein (n ¼ 12), and half (n ¼ 11)
of the patients showed no obvious clinical signs of penetrating
disease.
Thirteen patients (57%) with CD and internal ﬁstulae required
nutritional support. Of these 13 patients, 6 were severely malnour-
ished (malnutrition universal screening tool score ¼ 2; subjective
global assessment ¼ 3) and 7 had mild-to-moderate malnutrition
(malnutrition universal screening tool score ¼ 1; subjective global
assessment ¼ 2). All 13 patients were started on enteral nutrition
support according to standard practice. None needed parenteral
nutrition. No small bowel cancers or suspicious areas were identiﬁed
in loops by-passed by ﬁstulizing small bowel.
DISCUSSION
In our study, we found that MR is as reliable as CT scan in
precise identiﬁcation of ﬁstulising CD. Because clinical signs and
symptoms of ﬁstulising CD are subtle and do not always predict
penetrating disease, the application of MR should be encouraged
in all patients with CD with mild-to-moderate disease.
CT scan and more conventional diagnostic radiographic
procedures impart signiﬁcant quantities of ionizing radiation to
a predominantly young patient population requiring lifelong
TABLE 1. Patient Characteristics at Entry into the
Study
Age, yr
Median 48 47 53 51
Range 32–74 42–69 31–71 42–72
Body mass index
Median 21 21 22 23
Range 18–26 19–25 20–24 21–27
N 21 (21) 41 124
Women 14 3 26 63
Fistulae 22 4 41 —
CDAI 350 310 300 250
Nutritional risk
Overall 1 1 1 —
Range 1–2 1 1 —
Medications
Mesalazine 18 (18) 21 68
Azathioprine 14 (4) 24 31
6-MP 4 — 6
MTX 2 — — —
ADA or IFX 12 4 213 8
ADA, adalimumab; BMI, body mass index; IFX, inﬂiximab; 6-MP, 6-mercaptopurine;
MTX, methotrexate; N, number (Brackets stand for number duplication).
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imaging. Furthermore, standard diagnostic workup may include
cycles of repeated testing due to the sometimes low diagnostic
yield of standard procedures and the inability of conventional
ﬂuoroscopic contrast-enhanced studies to visualize extraenteric
manifestations of the disease, such as abscess or ﬁstula formation.
Perianal enterovesical ﬁstulae and rectovaginal ﬁstulae may not
always be well demonstrated at CT scan imaging. Although no
difference was seen in this study, MR examination may be
preferred for this reason (Fig. 2).
In our study, there was no clinical suspicion of penetrating
disease in half of the patients with ﬁstulae and abscess before CTE
and MRE. Moreover, the C reactive protein was normal in most
cases. As a result of modern comprehensive imaging, no fewer
than 33% of patients underwent a change in nutritional therapy
after the detection of ﬁstulising CD.
Treatment of ﬁstulae might also include drainage of acute
suppurative lesions in combination with prompt antibiotic treatment.
The therapeutic goals for ﬁstulising CD are to close ﬁstulae and
maintain their closure, to reduce the incidence of infections and
malnutrition in persisting ﬁstulas, and to limit the need for surgical
interventions. Clinical studies in ﬁstulising CD should reﬂect this, and
precise identiﬁcation of ﬁstulae is of key importance if maximal yield
is to be accrued. However, using MR as ﬁrst-line investigation in CD
is still a matter of debate, not least since it has been criticized for the
high operating costs and the need for contrast injection.17 Furthermore
in 2005, Mackalski and Bernstein18 compared MRE and small-bowel
follow through in 30 patients with CD and found that small-bowel
follow through allowed identiﬁcation of 2 ileocolic ﬁstulas that were
missed by using MR enterographic images.18
In contrast, further studies have provenMR to be very effective
in the assessment of small bowel abnormalities and to be particularly
capable of providing tissue-speciﬁc information on CD at its various
stages from acute inﬂammatory, regenerative, ﬁstulising, and perfo-
rating disease to the ﬁbrostenotic stage due to its excellent soft-tissue
contrast. Maccioni et al19 in a recent study including 59 patients with
suspected CD found 12 internal ﬁstulae, by using MRE. In this study,
CT scan was not considered in the preclinical workup and CDAI was
scored but not used as inclusion criteria, as in our study.
In 2009, Lee et al29 included 30 patients with suspected
CD, and magnetic resonance imaging was compared with other
techniques for the diagnosis of CD. In this study, 19 extraenteric
complications were found and the sensitivity and the speciﬁcity
of MRE and CT enterography methods resulted higher than
barium enema in demonstrating the small bowel involvement
in CD. In this study too, CT scan was part of the study’s
workup.30
FIGURE 1. The ﬁgure shows contrast-enhanced CTE and MRE of a patient with colonic localization of CD. Axial CT and MR images show the
sigmoid concentric involvement (A, B: arrowheads) characterized by homogeneously thickened visceral wall with blurring of the edges
between the outer wall of the colon and the surrounding fat. Multiple hyperhemic vessels are also easily depicted. To show the extensive
longitudinal involvement, a curved multiplanar reformation can be performed on CTE datasets to display in one single image the entire
segment (C: arrowhead); from the image, it is clear that the involvement of the colonic wall is extending from lower rectum up to mid de-
scending colon. There is no evidence of signiﬁcant stenosis or ﬁstula in this tract. Another curved multiplanar reformat shows the potential of
CTE and MRE for visualization of disease extension (D, E, F: arrowhead). The 2 modalities can basically provide similar information in this
context (CTE ¼ D, E; MRE ¼ F).
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The association of T2- and T1-weighted gadolinium-
enhanced sequences has now to be considered of highest diagnostic
accuracy, thus making MR imaging a powerful diagnostic tool in
the complete examination of patients with CD. Magnetic resonance
imaging can therefore be ﬁrmly recommended as the best technique
for the detection of extramural complication in CD.31
The groups of both Masselli and Umschaden have reported
high diagnostic accuracy in the clinical workup of CD, including
the detection of internal ﬁstulae.12,13 Indeed, there are many theo-
retical reasons why MR may be especially sensitive and appropri-
ate in the diagnosis of ﬁstulae, given rapid high-contrast resolution
image acquisition, encompassing both mural and extramural tis-
sues. Importantly, the technique does not impart ionizing radiation.
Like CT scan, it is capable of multiplanar images, aiding the
radiological interpretation. With modern hardware, very rapid
high-resolution imaging sequences are now available (such as
steady-state free precession sequences) permitting high-quality
images to be obtained in a single breath-hold and in part over-
coming artifacts generated by bowel peristalsis. Furthermore, MR
not only depicts the enteric changes of CD such as mural thicken-
ing, stricturing, and inﬂammation but also provides important
information about the extraenteric manifestations of the disease,
such as abscess or ﬁstula formation, vital for optimal patient man-
agement. Adequate bowel distension is important for accurate
cross-sectional diagnosis in CD, and MR seems particularly suc-
cessful in this. Furthermore, the application of MR to the study of
FIGURE 2. The ﬁgure shows contrast-enhanced CTE and MRE of a complex enteroenteric ﬁstula involving colon. MRE (precontrast ¼ A, post-
contrast ¼ B) and CTE (C) show the center of the ﬁstula in the mesenteric fat (arrowheads). A coronal multiplanar reformat shows the extent and
anatomy of the complex ﬁstula (arrowheads) both with contrast enhance MRE (D) and CTE (E). A maximum intensity projection algorithm applied
to coronal CTE (F) reformats perfectly shows the pattern of enhancement of the visceral wall (i.e., two-layer pattern with relatively hyper-enhanced
inner layer). The ﬁgure easily allows deﬁning an involvement of the distal ileal segment of the transverse colon and of the ileal loops.
FIGURE 3. CTE and MRE of CD allow depicting several different aspects of disease anatomy, distribution, and activity. Beside the very important
aspect of active disease (A, arrowhead: CTE of distal ileum with hyper-enhanced inner layer) or quiescent disease (B, arrowhead: distal ileum with
thickened walls but without signiﬁcant perivisceral fat stranding), it is possible and easy to depict, locate, and assess the nodal inﬂammation both
with MRE (C, arrowhead) and CTE (D, arrowheads).
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ﬁstulae may help in the early identiﬁcation of neoplasia in
bypassed intestinal loops (Fig. 3).
Patients with CD have a recognized relative risk of
developing small bowel adenocarcinoma. In a recent study, based
on a hospital cohort of 1935 patients with small bowel involvement,
the cumulative risk of small-bowel adenocarcinoma in CD (95%
conﬁdence interval) was estimated to be 2 (0–8) and 22 per 1000
patients (7–64) after 10 and 25 years of follow-up, respectively.32
In this study, no data have been displayed to corroborate the
existing link between ﬁstula and cancer development on the small
bowel bypassed loops, but the possibility of this complication
lends further support to the use of an axial imaging approach that
is capable of showing disease outside the principal alimentary
channel. Our study was, however, underpowered to detect small
bower cancer, into the study’s cohort.
A limitation of this study was the inclusion of patients with
CD with moderate disease only (CDAI, 250–450), excluding patients
with early-stage disease. This was a deliberate selection bias
explaining the quite high rate of ﬁstulising disease in our study
population and potentially increasing the diagnostic performance
of CTE and MRE.
Nevertheless, early disease manifestations such as superﬁ-
cial aphthous ulceration, mucosal nodularity, and erythema are
beyond the resolution of MR imaging and are probably still better
identiﬁed with endoscopic technique. Moreover, subtle wall
thickening is not well demonstrated at MR imaging, even with
full luminal distension. Moderately active disease instead and its
complications are clearly identiﬁed, with MRE, for moderate
disease being deliberated targeted in this study. It would perhaps
have been useful to assess the diagnostic capabilities of each of
the individual MRE sequences in their ability to detect ﬁstulae;
however, the MR examination was interpreted as a whole.
The results of this study may not apply to all patients with
CD. Incomplete luminal distension of the jejunal loops may occur
in MRE. Therefore, enteroclysis may still be necessary in some
patients with suspected jejunal disease. Complex enterocutaneous
ﬁstulae are sometimes not well deﬁned by MR, notably due to
compression or distortion caused by prone positioning or to ﬁeld
inhomogeneity caused by their localization. In this situation,
imaging with the patient supine may be helpful when enter-
ocutaneous ﬁstulae are suspected clinically.33
Other studies in CD have also reported MR to seem similar
to CT enterography/enteroclysis and superior to conventional
contrast-enhanced studies in diagnosing and depicting ﬁstulae and
disease extent in CD,34–37 and it should be acknowledged that
reference standards in CD are evolving rapidly. In the general
context of pelvic sepsis and anorectal ﬁstulae complicating CD,
anal endosonography has been reported as the best modality in 1
study.38 However, state of the art comparative data is clearly
warranted in CD. The lack of a need to introduce an endoluminal
device, unlimited view and perfect comparison between different
examinations, with less dependence on a specially skilled operator
favors MR, anal endosonography being a good alternative.39
CONCLUSIONS
CT enterography and MRE are of undoubted clinical value
in the diagnosis of all forms of ﬁstulae in CD. MR is preferable
FIGURE 4. Summary of investigatory pathway.
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given the avoidance of radiation burden. The better identiﬁcation
of internal ﬁstulae should facilitate earlier effective treatment of
ﬁstulae-related malabsorption and malnutrition (Fig. 4).
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